Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 30 04 2023
accepted: 05 09 2023
medline: 23 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: epublish

Résumé

Immunoglobulin G (IgG) contains a conserved N-glycan in the fragment crystallizable (Fc), modulating its structure and effector functions. In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) alterations of IgG Fc-glycosylation have been observed to correlate with the disease course. Here, we examined longitudinal changes in N Using liquid chromatography coupled with mass spectrometry, we analysed IgG Fc-glycosylation in 410 longitudinal samples from 96 individuals with AAV. Analysis of the cross-sectional differences as well as longitudinal changes demonstrated that IgGs of relapsing PR3-ANCA patients have higher ΔFc-bisection at diagnosis ( Our data indicate that IgG Fc-bisection correlates with long-term treatment outcome, while lower IgG Fc-fucosylation and sialylation associate with impending relapse. Overall, our study replicated the previously published reduction in total IgG Fc-sialylation at the time of relapse, but showed additionally that its onset precedes relapse. Furthermore, our findings on IgG fucosylation and bisection are entirely new. All these IgG Fc-glycosylation features may have the potential to predict a relapse either independently or in combination with known risk factors, such as a rise in ANCA titre.

Identifiants

pubmed: 37841251
doi: 10.3389/fimmu.2023.1214945
pmc: PMC10570725
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0
Immunoglobulin G 0
Immunoglobulin Fragments 0
Polysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1214945

Informations de copyright

Copyright © 2023 Wojcik, Wuhrer, Heeringa, Stegeman, Rutgers and Falck.

Déclaration de conflit d'intérêts

IW was employed by Genos Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):271-294
pubmed: 30527432
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Front Immunol. 2017 Aug 02;8:877
pubmed: 28824618
Immunity. 2023 Jan 10;56(1):180-192.e11
pubmed: 36563676
N Engl J Med. 2012 Jul 19;367(3):214-23
pubmed: 22808956
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115-9
pubmed: 2161532
Ann Rheum Dis. 2016 Sep;75(9):1583-94
pubmed: 27338776
Methods Mol Biol. 2017;1503:31-47
pubmed: 27743357
PLoS One. 2017 Aug 3;12(8):e0182549
pubmed: 28771641
Nat Rev Rheumatol. 2014 Aug;10(8):463-73
pubmed: 25003769
J Leukoc Biol. 2003 Jul;74(1):3-15
pubmed: 12832437
J Proteomics. 2012 Feb 2;75(4):1318-29
pubmed: 22120122
EBioMedicine. 2017 Mar;17:108-118
pubmed: 28169190
Curr Rheumatol Rep. 2019 May 23;21(7):33
pubmed: 31123922
J Proteome Res. 2015 Sep 4;14(9):4019-28
pubmed: 26244886
J Clin Invest. 2015 Nov 2;125(11):4160-70
pubmed: 26436649
J Transl Autoimmun. 2021 Mar 03;4:100094
pubmed: 33912820
Rheumatol Int. 2021 Oct;41(10):1717-1728
pubmed: 34383129
J Am Soc Nephrol. 2010 Jul;21(7):1103-14
pubmed: 20448018
J Proteome Res. 2016 Jul 1;15(7):2198-210
pubmed: 27267458
Cell Immunol. 2018 Nov;333:65-79
pubmed: 30107893
J Proteome Res. 2015 Apr 3;14(4):1657-65
pubmed: 25761865
Br J Haematol. 2014 Sep;166(6):936-45
pubmed: 24909983
Mol Cell Proteomics. 2011 May;10(5):M110.004655
pubmed: 21372248
Sci Rep. 2021 Dec 15;11(1):24045
pubmed: 34911982
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Nat Rev Rheumatol. 2019 Feb;15(2):91-101
pubmed: 30542206
Blood. 2014 Jan 23;123(4):471-80
pubmed: 24243971
Front Med (Lausanne). 2022 Jul 04;9:844112
pubmed: 35860735
Nephrol Dial Transplant. 1993;8(8):696-702
pubmed: 8414154
Science. 2021 Feb 26;371(6532):
pubmed: 33361116
J Biol Chem. 2003 Jan 31;278(5):3466-73
pubmed: 12427744
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20736-41
pubmed: 22147912
Arthritis Rheum. 2012 Feb;64(2):542-8
pubmed: 21953279
Clin Exp Immunol. 2002 Jul;129(1):183-90
pubmed: 12100039
Front Immunol. 2022 Jan 24;12:724379
pubmed: 35140700
Kidney Int Rep. 2022 Sep 20;7(12):2676-2690
pubmed: 36506241
Arthritis Rheum. 2012 Oct;64(10):3452-62
pubmed: 23023777
J Clin Invest. 2019 Sep 3;129(9):3492-3498
pubmed: 31478910
Science. 2006 Aug 4;313(5787):670-3
pubmed: 16888140
PLoS One. 2019 Feb 28;14(2):e0213215
pubmed: 30818380
Am J Pathol. 2009 Apr;174(4):1212-20
pubmed: 19264905
Int Immunol. 2017 Jul 1;29(7):303-310
pubmed: 28472280
Kidney Int. 2021 Oct;100(4S):S1-S276
pubmed: 34556256
Blood. 2013 Nov 14;122(20):3482-91
pubmed: 24106207
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Biochim Biophys Acta. 2006 Apr;1760(4):669-77
pubmed: 16413679
J Biol Chem. 2002 Jul 26;277(30):26733-40
pubmed: 11986321
Eur J Hum Genet. 2001 Oct;9(10):765-72
pubmed: 11781688
Ann Rheum Dis. 2007 May;66(5):605-17
pubmed: 17170053
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):779-89
pubmed: 24325898

Auteurs

Iwona Wojcik (I)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

Manfred Wuhrer (M)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

Peter Heeringa (P)

Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands.

Coen A Stegeman (CA)

Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands.

Abraham Rutgers (A)

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands.

David Falck (D)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH